These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11694155)

  • 1. Association between myeloperoxidase levels and risk of coronary artery disease.
    Zhang R; Brennan ML; Fu X; Aviles RJ; Pearce GL; Penn MS; Topol EJ; Sprecher DL; Hazen SL
    JAMA; 2001 Nov; 286(17):2136-42. PubMed ID: 11694155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between adipokine and myeloperoxidase levels in patients with coronary artery disease.
    Basati G; Emami Razavi A; Abdi S; Sarrafzadegan N
    Acta Med Iran; 2015; 53(1):25-9. PubMed ID: 25597601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes.
    Song P; Xu J; Song Y; Jiang S; Yuan H; Zhang X
    Dis Markers; 2015; 2015():761939. PubMed ID: 26451069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
    Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
    Variji A; Shokri Y; Fallahpour S; Zargari M; Bagheri B; Abediankenari S; Alizadeh A; Mahrooz A
    Atherosclerosis; 2019 Jan; 280():7-13. PubMed ID: 30448568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study.
    Chen LQ; Rohatgi A; Ayers CR; Das SR; Khera A; Berry JD; McGuire DK; de Lemos JA
    Atherosclerosis; 2011 Dec; 219(2):833-8. PubMed ID: 21917261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
    Kubala L; Lu G; Baldus S; Berglund L; Eiserich JP
    Clin Chim Acta; 2008 Aug; 394(1-2):59-62. PubMed ID: 18440308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease.
    Wainstein RV; Wainstein MV; Ribeiro JP; Dornelles LV; Tozzati P; Ashton-Prolla P; Ewald IP; Vietta G; Polanczyk CA
    Clin Biochem; 2010 Jan; 43(1-2):57-62. PubMed ID: 19651119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease.
    Trentini A; Rosta V; Spadaro S; Bellini T; Rizzo P; Vieceli Dalla Sega F; Passaro A; Zuliani G; Gentili V; Campo G; Cervellati C
    Clin Chem Lab Med; 2020 Sep; 58(10):1749-1758. PubMed ID: 32031967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.
    Shishehbor MH; Aviles RJ; Brennan ML; Fu X; Goormastic M; Pearce GL; Gokce N; Keaney JF; Penn MS; Sprecher DL; Vita JA; Hazen SL
    JAMA; 2003 Apr; 289(13):1675-80. PubMed ID: 12672736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
    Rho YH; Chung CP; Oeser A; Solus J; Asanuma Y; Sokka T; Pincus T; Raggi P; Gebretsadik T; Shintani A; Stein CM
    Arthritis Rheum; 2009 Nov; 61(11):1580-5. PubMed ID: 19877084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome.
    Blanchet X; Cesarek K; Brandt J; Herwald H; Teupser D; Küchenhoff H; Karshovska E; Mause SF; Siess W; Wasmuth H; Soehnlein O; Koenen RR; Weber C; von Hundelshausen P
    Thromb Haemost; 2014 Dec; 112(6):1277-87. PubMed ID: 25183015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography.
    Cavusoglu E; Chopra V; Gupta A; Ruwende C; Yanamadala S; Eng C; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2006 Nov; 98(9):1189-93. PubMed ID: 17056325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-vessel gradient of myeloperoxidase in coronary artery disease.
    Alipour A; Ribalta J; Njo TL; Janssen HW; Birnie E; van Miltenburg AJ; Elte JW; Castro Cabezas M
    Eur J Clin Invest; 2013 Sep; 43(9):920-5. PubMed ID: 23869443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and total myeloperoxidase in coronary artery disease and relation to clinical instability.
    Gach O; Brogneaux C; Franck T; Serteyn D; Legrand V; Pierard LA; Magne J
    Acta Cardiol; 2015 Oct; 70(5):522-7. PubMed ID: 26567811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.